Contact Us
Find A Doctor

EYEGATE Clinical Trial

Purpose

The purpose of this study is to evaluate the safety and efficacy of ocular iontophoresis with dexamethasone phosphate ophthalmic solution EGP-437 using the EyeGateà ,�� II Drug Delivery System (EGDS) compared to prednisolone acetate ophthalmic suspension (1%) in patients with non-infectious anterior segment uveitis.

Eligibility

Dr. C. Michael Samson, Uveitis Specialist and Principal Investigator of this study can determine if you are eligible.

You may qualify if you:

  • are Male or female, age 12 to 85 years with a diagnosis of non-infectious anterior segment uveitis defined as an anterior chamber cell count of ? 11 cells
  • Other protocol-defined inclusion/exclusion criteria may apply

This is a fully funded trial. All research related procedures and medication will be at no cost to the patient.

 

 

Contact Us

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations